Edition:
United States

Veloxis Pharmaceuticals A/S (VELOX.CO)

VELOX.CO on Copenhagen Stock Exchange

1.05DKK
24 May 2017
Change (% chg)

kr.-0.01 (-0.94%)
Prev Close
kr.1.06
Open
kr.1.06
Day's High
kr.1.06
Day's Low
kr.1.04
Volume
402,321
Avg. Vol
1,036,038
52-wk High
kr.1.49
52-wk Low
kr.0.93

Select another date:

Wed, May 17 2017

BRIEF-Veloxis Pharmaceuticals Q1 operating loss narrows to $5.2 mln

* VELOXIS MAINTAINS ITS 2017 OUTLOOK OF OPERATING LOSS BEFORE THE RECOGNITION OF INCOME FROM LICENSE AGREEMENTS AND BEFORE ACCOUNTING FOR STOCK COMPENSATION TO BE IN THE RANGE OF USD 5 – 15 MILLION.

BRIEF-Veloxis increases share capital in connection with exercise of warrants

* CAPITAL INCREASED BY 1,000,000 NEW SHARES WITH A NOMINAL VALUE OF DKK 0.10 EACH CORRESPONDING TO NOMINALLY DKK 100,000 AS A CONSEQUENCE OF EXERCISE OF WARRANTS

BRIEF-Veloxis Pharmaceuticals announces New Jersey office closure

* US subsidiary, Veloxis Pharmaceuticals Inc., has decided to close its office in Edison, New Jersey effective February 28, 2017

BRIEF-Veloxis Pharmaceuticals announces amended and restated loan and security agreement

* Agreed to amend and restate terms of its previously announced loan and security agreement with Lundbeckfond Invest A/S and Novo A/S.

Select another date:

More From Around the Web